Cocoa Supplementation, Inflammaging, and Epigenetic Aging
NCT ID: NCT05510375
Last Updated: 2022-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
21442 participants
INTERVENTIONAL
2015-06-30
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
NCT00541164
Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans
NCT02340845
Everycell's Effect on DNA Damage, Inflammation, and Stress
NCT02032693
Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC)
NCT06064838
Safety and Tolerability of LIM-0705 in Healthy Male Subjects
NCT01060475
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cocoa extract + multivitamin
Two capsules/day for 600 mg/day of cocoa flavanols One tablet/day of multivitamin
Cocoa extract
2 capsules each day containing a total of 500 mg cocoa flavanols, including 80 mg (-)-epicatechin, and 50 mg theobromine
Multivitamin
Multivitamin
Cocoa extract + multivitamin placebo
Two capsules/day for 600 mg/day of cocoa flavanols Multivitamin placebo
Cocoa extract
2 capsules each day containing a total of 500 mg cocoa flavanols, including 80 mg (-)-epicatechin, and 50 mg theobromine
Multivitamin placebo
Multivitamin placebo
Cocoa extract placebo + multivitamin
Cocoa extract placebo One tablet/day of multivitamin
Multivitamin
Multivitamin
Cocoa extract placebo
Cocoa extract placebo
Cocoa extract placebo + multivitamin placebo
Cocoa extract placebo Multivitamin placebo
Cocoa extract placebo
Cocoa extract placebo
Multivitamin placebo
Multivitamin placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cocoa extract
2 capsules each day containing a total of 500 mg cocoa flavanols, including 80 mg (-)-epicatechin, and 50 mg theobromine
Multivitamin
Multivitamin
Cocoa extract placebo
Cocoa extract placebo
Multivitamin placebo
Multivitamin placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Opted to use EMSI for longitudinal blood collections, during which seated BPs were additionally measured.
Exclusion Criteria
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
Augusta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1687423
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.